Towards neoantigen targeting personalized cancer immunotherapies which actually work

Dr. Rubinsteyn's research sits at the intersection of genomics, immunology, and machine learning. He previously helped design and run three personalized cancer vaccine trials at the Icahn School of Medicine at Mount Sinai. Now at UNC, he helps run the multi-PI Personalized Immunotherapy Research Lab. The lab is working to overturn the limitations of existing therapeutic approaches and translate new ideas into clinical trials with therapeutic benefit.